Lilly direct-selling Zepbound at $499/mo — compare with 11 other programs

Wegovy vs Rybelsus

Editorial comparison of Wegovy (semaglutide) and Rybelsus (semaglutide (oral)). Same drug class context, trial-anchored data, no marketing claims.

Reviewed by the glpzoom Editorial Team against primary clinical sources — FDA labeling, peer-reviewed trials, and specialty-society guidelines.
Content current as of June 2026; updated when guidance or availability changes.

Side-by-side

DimensionWegovyRybelsus
Generic namesemaglutidesemaglutide (oral)
ManufacturerNovo NordiskNovo Nordisk
FDA approved20212019
MechanismSemaglutide mimics GLP-1, a gut hormone released after meals.GLP-1 receptor agonist, identical mechanism to injectable semaglutide.
DosingTitrated over 4-5 months: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg, increasing every 4 weeks.Once daily on an empty stomach with ≤4 oz water, 30 minutes before food/drink/other meds. Titrated 3mg → 7mg → 14mg.
CostList price ~$1,350/month without insurance.List ~$900-1,000/month. Diabetes coverage generally better than weight-loss coverage. NovoCare self-pay options available for eligible patients.
Pivotal trial result14.9% mean body-weight reduction at 68 weeks

Full Wegovy review →

Once-weekly injectable semaglutide for chronic weight management. ~15% body weight loss in trials.

Full Rybelsus review →

Oral semaglutide tablet for type 2 diabetes. Same molecule as Ozempic/Wegovy in pill form, with strict fasting-and-water dosing rules.

Frequently asked

Is Wegovy or Rybelsus more effective?+

In their pivotal trials, Wegovy reported 14.9% mean body-weight reduction at 68 weeks, while Rybelsus reported no headline result on file. Head-to-head results vary by patient profile, dose tolerated, and adherence — these trial numbers describe averages, not what every individual experiences.

How do Wegovy and Rybelsus compare on cost?+

Wegovy: List price ~$1,350/month without insurance. With Novo Nordisk's patient assistance program, eligible self-pay patients can access at $200-500/month. Insurance coverage is patchy and often requires prior authorization plus a documented weight-related comorbidity. Rybelsus: List ~$900-1,000/month. Diabetes coverage generally better than weight-loss coverage. NovoCare self-pay options available for eligible patients. Real out-of-pocket depends on insurance formulary tier, manufacturer savings programs, and whether a direct-pay channel is available.

Can I switch from Wegovy to Rybelsus?+

Switching between brand-name treatments in the same drug class is common, but the conversion is not always 1:1. Discuss the switch with your prescriber — they'll usually re-titrate dosing rather than substitute equivalent strengths directly.

Are Wegovy and Rybelsus the same drug?+

No. Wegovy (semaglutide) and Rybelsus (semaglutide (oral)) are distinct medications from Novo Nordisk and Novo Nordisk respectively. They may share a drug class or mechanism but differ in active ingredient, dosing, and approved use.

We may earn a commission when you click links to partners. Affiliate disclosure.